Skip to Main Content

Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?

This study has been completed.

Sponsor:

Information provided by:

Sorlandet Hospital HF

ClinicalTrials.gov Identifier:

NCT00202709

First received: September 12, 2005

Last updated: July 27, 2011

Last verified: September 2005

History of Changes

Tracking Information

First Received Date ^ICMJE

September 12, 2005

Last Updated Date

July 27, 2011

Start Date ^ICMJE

May 2002

Primary Completion Date

August 2003 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R) [ Time Frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment. ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Global symptom index (gsi) on the Symptom checklist 90 revised (SCL-90-R)

Change History

Complete list of historical versions of study NCT00202709 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Davidson Trauma Scale [ Time Frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment. ] [ Designated as safety issue: No ]
Liebowitz Social Anxiety Scale [ Time Frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment. ] [ Designated as safety issue: No ]
Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment. ] [ Designated as safety issue: No ]
Fear Questionnaire (FQ) [ Time Frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment. ] [ Designated as safety issue: No ]
Sheehan Disability Scale [ Time Frame: Before treatment/wait list period, just after treatment, 3 months and 12 months after treatment. Group A also 6 months after treatment. ] [ Designated as safety issue: No ]

Original Secondary Outcome Measures ^ICMJE

Davidson Trauma Scale
Liebowitz Social Anxiety Scale
Hospital Anxiety and Depression Scale (HADS)
Fear Questionnaire (FQ)
Sheehan Disability Scale

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder?

Official Title ^ICMJE

Can Thought Field Therapy (TFT) be Helpful for Patients With an Anxiety Disorder, a Prospective, Randomized Pilot Study With Wait List as Control Group.

Brief Summary

The purpose of this study is to find out if Thought Field Therapy has effect on certain anxiety disorders; agoraphobia, social phobia, and post traumatic stress disorder (PTSD).

Detailed Description

Thought Field Therapy is an alternative treatment method that has been shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 52 patients, with one or more of the diagnoses agoraphobia, social phobia and/or PTSD, where randomized to either treatment with TFT or a wait list. The treatment group all got treatment in one week. 2 1/2 months later both the treatment group and the control group were tested on the same items as before the treatment started. After this evaluation phase the control group got the same treatment as the treatment or study group. Both groups were evaluated 3 and 12 months after treatment, the study group also 6 months after treatment. 4 patients were omitted because they changed groups. The study were performed from May 2002 until June 2003.

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Condition ^ICMJE

Agoraphobia
Social Phobia
PTSD

Intervention ^ICMJE

Behavioral: Thought Field Therapy (TFT)

Treatment with TFT twice in one week

Other Name: Wait list control

Study Arm (s)

Experimental: Thought Field Therapy (TFT)
Treatment with TFT, first one hour, then 1/2 hour.

Intervention: Behavioral: Thought Field Therapy (TFT)
No Intervention: Wait list control

Publications *

Irgens A, Dammen T, Nysæter TE, Hoffart A. Thought Field Therapy (TFT) as a treatment for anxiety symptoms: a randomized controlled trial. Explore (NY). 2012 Nov;8(6):331-8. doi: 10.1016/j.explore.2012.08.002.

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

52

Completion Date

August 2003

Primary Completion Date

August 2003 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

One or more of the study diagnoses agoraphobia, social phobia and/or PTSD

Exclusion Criteria:

Ongoing psychosis
Ongoing serious drug problems

Gender

Both

Ages

Not Provided

Accepts Healthy Volunteers

No

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Norway

Administrative Information

NCT Number ^ICMJE

NCT00202709

Other Study ID Numbers ^ICMJE

SSHF-AUIR-1

Has Data Monitoring Committee

No

Responsible Party

Audun Irgens, MD, Sorlandet sykehus HF

Study Sponsor ^ICMJE

Sorlandet Hospital HF

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Audun C Irgens, MD

Sorlandet Hospital HF

Information Provided By

Sorlandet Hospital HF

Verification Date

September 2005

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP